Animol

Identifying better medicines to deliver better care

Founded 2019 · $34.0M raised

Founded
2019
Business Model
B2B
Total Funding
$34.0M
Last Round
$34.0M Series BJul 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Animol Discovery is a biopharmaceutical company focused on discovering novel active pharmaceutical ingredients to transform outcomes for animal patients. It is building a pipeline of proprietary veterinary small molecules for companion and farm animals, with projects ranging from anti-parasitics to chronic diseases, led by animal-health industry experts in drug discovery and development. Using a unique technology platform, Animol designs innovative medicines specifically for veterinary needs rather than adapting human drugs.

Summary

Animol is a Biotech company, founded in 2019. It has raised $34.0M in total across 1 round, most recently a $34.0M Series B round in Jul 2022. Investors include Kenneth Chien / Novalis LifeSciences, Finistere Ventures and Anterra Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJul 2022
$34.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Animol on Indexed.vc
<a href="https://indexed.vc/companies/animol"><img src="https://indexed.vc/api/badge/company/animol" alt="Animol on Indexed.vc" width="260" height="76" /></a>